Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-046788

VP, Chief Accounting Officer acquired 1,530 shares (other)

  • VP, Chief Accounting Officer gave up 191 shares (to pay taxes)
  • VP, Chief Accounting Officer acquired 552 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2021-04-30 Other acquisition +1,530 $13.90 $21,263 13,475 D: show line 1 in the form
Peraza Lisa VP, Chief Accounting Officer 2021-07-13 Option exercise +552 14,027 D: show line 2 in the form
Peraza Lisa VP, Chief Accounting Officer 2021-07-13 Shares withheld for taxes −191 $13.48 $2,575 13,836 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peraza Lisa VP, Chief Accounting Officer 2021-07-13 Option exercise · Restricted Stock Units −552 7,177 D: show line 4 in the form
Loading xslF345X03/doc4.xml…